The Supernus Pharmaceuticals brand, founded in 2005 (United States), from 1 sister brand and 4958 competing brands. Supernus Pharmaceuticals is owned by Supernus Pharmaceuticals, listed on the stock exchange of New York Supernus Pharmaceuticals is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Supernus Pharmaceuticals
over 5 years*
USD 25.01